32.26
2.39 (8.00%)
| Penutupan Terdahulu | 29.87 |
| Buka | 30.54 |
| Jumlah Dagangan | 2,202,719 |
| Purata Dagangan (3B) | 2,569,639 |
| Modal Pasaran | 2,806,473,984 |
| Harga / Pendapatan (P/E Ke hadapan) | 98.04 |
| Harga / Jualan (P/S) | 41.65 |
| Harga / Buku (P/B) | 133.10 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2025 |
| Margin Operasi (TTM) | -1,135.42% |
| EPS Cair (TTM) | -1.71 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 297.04% |
| Nisbah Semasa (MRQ) | 2.93 |
| Aliran Tunai Operasi (OCF TTM) | -99.23 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -64.38 M |
| Pulangan Atas Aset (ROA TTM) | -37.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -203.98% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Liquidia Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.20 |
|
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 13.64% |
| % Dimiliki oleh Institusi | 65.04% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 52.00 (Needham, 61.19%) | Beli |
| Median | 50.00 (54.99%) | |
| Rendah | 49.00 (BTIG, 51.89%) | Beli |
| Purata | 50.33 (56.01%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 27.91 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 04 Nov 2025 | 49.00 (51.89%) | Beli | 27.91 |
| HC Wainwright & Co. | 04 Nov 2025 | 50.00 (54.99%) | Beli | 27.91 |
| 06 Oct 2025 | 35.00 (8.49%) | Beli | 22.86 | |
| Needham | 04 Nov 2025 | 52.00 (61.19%) | Beli | 27.91 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ADAIR JASON | - | 32.05 | -693 | -22,211 |
| BOYLE DANA | - | 32.05 | -303 | -9,711 |
| KASETA MICHAEL | - | 32.05 | -1,166 | -37,370 |
| KREPP SARAH | - | 32.05 | -221 | -7,083 |
| MOOMAW SCOTT | - | 32.05 | -831 | -26,634 |
| SCHUNDLER RUSSELL | - | 32.05 | -1,072 | -34,358 |
| Jumlah Keseluruhan Kuantiti Bersih | -4,286 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -137,366 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 32.05 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MOOMAW SCOTT | Pegawai | 01 Dec 2025 | Jual automatik (-) | 831 | 32.05 | 26,634 |
| ADAIR JASON | Pegawai | 01 Dec 2025 | Jual automatik (-) | 693 | 32.05 | 22,211 |
| BOYLE DANA | Pegawai | 01 Dec 2025 | Jual automatik (-) | 303 | 32.05 | 9,711 |
| KASETA MICHAEL | Pegawai | 01 Dec 2025 | Jual automatik (-) | 1,166 | 32.05 | 37,370 |
| KREPP SARAH | Pegawai | 01 Dec 2025 | Jual automatik (-) | 221 | 32.05 | 7,083 |
| SCHUNDLER RUSSELL | Pegawai | 01 Dec 2025 | Jual automatik (-) | 1,072 | 32.05 | 34,358 |
| MOOMAW SCOTT | Pegawai | 28 Nov 2025 | Pelaksanaan pilihan | 1,875 | - | - |
| ADAIR JASON | Pegawai | 28 Nov 2025 | Pelaksanaan pilihan | 1,563 | - | - |
| KASETA MICHAEL | Pegawai | 28 Nov 2025 | Pelaksanaan pilihan | 2,343 | - | - |
| SCHUNDLER RUSSELL | Pegawai | 28 Nov 2025 | Pelaksanaan pilihan | 2,343 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Nov 2025 | Pengumuman | Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences |
| 03 Nov 2025 | Pengumuman | Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update |
| 27 Oct 2025 | Pengumuman | Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 |
| 07 Oct 2025 | Pengumuman | Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 |
| 29 Sep 2025 | Pengumuman | Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting |
| 11 Sep 2025 | Pengumuman | Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |